Vertex Pharmaceuticals (VRTX) Earnings Date & Reports

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

VRTX is expected to report earnings to rise 6.40% to $4.32 per share on July 31

Vertex Pharmaceuticals VRTX Stock Earnings Reports

Q2'25

Est.

$4.32

Q1'25

Missed

by $0.20

Q4'24

Missed

by $0.04

Q3'24

Beat

by $0.30

Q2'24

Missed

by $1.13

The last earnings report on May 05 showed earnings per share of $4.06, missing the estimate of $4.26. With 1.64M shares outstanding, the current market capitalization sits at 109.14B.

View a ticker or compare two or three

Compare

VRTX